Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Chinese Journal of Radiological Medicine and Protection ; (12): 192-196, 2018.
Article in Chinese | WPRIM | ID: wpr-708039

ABSTRACT

Objective To compare the efficacy of trimodality therapy and chemoradiation therapy (CRT) alone in patients with locally advanced resectable esophageal squamous cell carcinoma (SCC).Methods A total of 124 cases with locally advanced resectable esophageal SCC were retrospectively analyzed and classified into 2 groups.Fifty-four cases in trimodality group were treated with surgery and preoperative chemoradiation,while 70 cases in CRT alone group only received radiation and chemotherapy.Local tumor control,3-year survival and treatment-related mortality were assessed.Results The local recurrent rate of the resected patients was 18.5% in trimodality group and 35.7% in CRT alone group,respectively(x2 =4.445,P < 0.05).The 3-year progression-free survival (PFS) was 65.3% (95% CI 50.7-80.5) in trimodality group and31.9% (95%CI 19.6-44.2) in CRT alone group (P<0.05),while the overall survival (OS) 66.3% (95% CI43.0-89.6) and 34.4% (95% CI 21.1-47.7),respectively(P < 0.05).Treatment-related mortality was 1.9% in trimodality group and 2.9% in CRT alone group (P > 0.05).For CRT alone group,the sub-group analysis showed that there was no statistically significant difference in the 3-year OS between patients who received 50-50.4 Gy and those who received the dose over 50.4 Gy (39.9% 95% CI 18.5-61.3 vs.31.5% 95% CI 14.8-48.2,P >0.05).Conclusions Compared with CRT alone,trimodality therapy showed the superior local control,PFS and OS,with similar treatment-related mortality in the treatment of patients with SCC of esophagus.The role of surgery could not be replaced by CRT alone even with the augment of radiation dose.

SELECTION OF CITATIONS
SEARCH DETAIL